Abhishek Bhardwaj
Internal Medicine · Darby, PANPI 1578844783
Payments from drug & device makers
Across 250 payments — averaging $439.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$62K
- AstraZeneca$44K
- Inari Medical, Inc.$403
- Actelion Pharmaceuticals US, Inc.$395
- Boehringer Ingelheim$344
- Stryker$287
- plus $2K from 25 others
What the payments were for
- Speaking & faculty fees$88,69081%
- Travel & lodging$12,43711%
- Food & beverage$8,5118%
- Education$2970%
- Gifts$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 96 | $62,196 |
| AstraZeneca | 69 | $44,446 |
| Inari Medical, Inc. | 8 | $403 |
| Actelion Pharmaceuticals US, Inc. | 5 | $395 |
| Boehringer Ingelheim | 7 | $344 |
| Stryker | 4 | $287 |
| Grifols USA, LLC | 8 | $208 |
| Amgen | 5 | $207 |
| Genentech USA, Inc. | 2 | $134 |
| UCB, Inc. | 1 | $134 |
| AbbVie | 6 | $127 |
| Baxter Healthcare | 3 | $127 |
| Verona Pharma, Inc. | 1 | $120 |
| Collegium Pharmaceutical, Inc. | 5 | $115 |
| Regeneron Healthcare Solutions, Inc. | 3 | $96 |
| Johnson & Johnson(2 entities) | 4 | $80 |
| Insmed, Inc. | 3 | $70 |
| Mylan Specialty L.p. | 2 | $56 |
| Sanofi | 2 | $56 |
| Electromed, Inc. | 3 | $48 |
| Pfizer | 2 | $38 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $35 |
| Vertex | 1 | $33 |
| Pulmonx Corporation | 1 | $33 |
| Boston Scientific | 1 | $32 |
| Merck | 1 | $29 |
| Viatris Specialty LLC | 1 | $25 |
| Fresenius Kabi USA, LLC | 1 | $24 |
| Valinor Pharma, LLC | 1 | $20 |
| Masimo Corporation | 1 | $19 |
| Novo Nordisk | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$109,953 in reported general payments places this provider in the 95th percentile of 5,705 internal medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 21 | $235,680 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 81 | $59,625 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $12,481 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $5,597 |
| BreynaBudesonide/Formoterol Fumarate | 24 | $4,953 |
| SymbicortBudesonide/Formoterol Fumarate | 20 | $4,556 |
| Wixela InhubFluticasone Propion/Salmeterol | 55 | $3,868 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 43 | $3,814 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 88 | $1,953 |
| Pantoprazole Sodium | 17 | $214 |
| Fluticasone Propionate | 14 | $201 |
| Prednisone | 51 | $188 |
| Azithromycin | 18 | $104 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $84 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev | $344 | $235,68021 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $62,196 | $65,22294 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $44,446 | $17,03735 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,705 internal medicine providers in Pennsylvania.
Other internal medicine in Darby
- Jonathan EpsteinPhiladelphia$13.1M
- Siddharth ShethPittsburgh$11M
- Nathan PatelTannersville$9.5M
- Pitamber DevgonPhiladelphia$7.5M
- Christopher StillDanville$7.1M
- Liza VillaruzPittsburgh$6.6M
- Paul HartleyUniontown$4.9M
- Victor KoladeSayre$4.7M
- Michael OliverBeaver$4.7M
- Raman PurighallaPittsburgh$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.